Skip to content

A Study of Two Modern Eye Surgery Methods in Patients

COMPARATIVE EVALUATION OF TOPICAL SUPRACAPSULAR PHACOEMULSIFICATION VERSUS STOP-AND-CHOP TOPICAL PHACOEMULSIFICATION IN CATARACT SURGERY: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL - Comparative Evaluation Of Topical Supracapsular Phacoemulsification Versus Stop-And-Chop Topical Phacoemulsification In Cataract Surgery: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112448
Enrollment
84
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Intervention2: NIL: NIL

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 50 years or older Diagnosed with age related or senile cataract Nuclear sclerosis grade 2 to 4 according to the Lens Opacities Classification System III No other significant lens opacity, with posterior subcapsular cataract and cortical cataract grade less than 2 Suitable for phacoemulsification under topical anesthesia Anticipated pupillary dilatation of at least 6 millimeters after instillation of tropicamide and phenylephrine Adequate pupillary dilatation expected to allow supracapsular prolapse of the nucleus during surgery

Exclusion criteria

Exclusion criteria: Corneal pathology including corneal dystrophy corneal opacity or previous corneal surgery Preoperative endothelial cell density below 1500 cells per square millimeter Complicated cataract including traumatic cataract subluxated cataract posterior polar cataract mature cataract hypermature cataract or white cataract Previous intraocular surgery in the study eye Coexisting ocular pathology affecting visual outcome including pseudoexfoliation syndrome zonular weakness previous corneal refractive surgery uncontrolled glaucoma active uveitis or retinal pathology Use of systemic steroids or immunosuppressive medications

Design outcomes

Primary

MeasureTime frame
To compare best corrected visual acuity (BCVA) at 1 day, 2 week, and 4 weeks postoperativelyTimepoint: To compare best corrected visual acuity (BCVA) at 1 day, 2 week, and 4 weeks postoperatively

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR PRAVIN TIDAKE

Datta Meghe Institute of Higher Education and Research

drpravinktidake75@gmail.com7887476011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026